BT announces new Clinical Board to bolster company’s Healthcare ambitions
Eight NHS clinicians join clinical advisory board from January
BT today announced the creation of a Clinical Advisory Board, comprised of experienced healthcare professionals, to drive the growth of new connected healthcare solutions which will deliver better outcomes and experiences for the NHS and patients. BT’s new Clinical Advisory Board will include eight leading NHS clinicians who will work hand-in-hand with BT to ensure its healthcare products and solutions are created to better meet the needs of NHS colleagues and which are linked to better patient and system outcomes.
With decades of experience between them, Dr Peter Ingham, Dr Michael Quinn, Professor Ann-Marie Cannaby, Dr Sandeep Bhansal and Dr Mateen Jiwani will bring deep insight and understanding to ensure that BT’s connected healthcare solutions are fully trialled, tested and embedded with direct feedback from NHS colleagues before they are deployed into a hospital environment. This will help to ensure that the NHS’ strategic ambitions around digital transformation are rooted in clinician and operational utility and have the support and endorsement of world-class NHS clinicians before they are used in healthcare settings.
In its first few months, the Clinical Advisory Board will support BT’s Enterprise unit on its health strategy, execution plans and tech solutions to ensure they are hardwired with the clinical and data governance necessary and can successfully be scaled at NHS locations right across the country. Whilst this is the first tranche of clinicians, further specialists will be onboarded in the new year.
Professor Sultan Mahmud, Healthcare Director, BT’s Enterprise unit, said: “I am delighted that BT has secured a group of top-class clinicians from the NHS with hands on experience of change management, technology and new care models. This demonstrates BT's commitment in supporting the digital transformation of the NHS, which is critical for its future sustainability. As a national enabler for the UK, it’s vital that we have experts on board who can advocate for our working heroes of the NHS as well as the health and wellbeing of our citizens who rely on the NHS day in, day out.”
BT Group is the UK’s leading telecommunications and network provider and a leading provider of global communications services and solutions, serving customers in 180 countries. Its principal activities in the UK include the provision of fixed voice, mobile, broadband and TV (including Sport) and a range of products and services over converged fixed and mobile networks to consumer, business and public sector customers. For its global customers, BT provides managed services, security and network and IT infrastructure services to support their operations all over the world. BT consists of four customer-facing units: Consumer, Enterprise, Global and its wholly-owned subsidiary, Openreach, which provides access network services to over 650 communications provider customers who sell phone, broadband and Ethernet services to homes and businesses across the UK.
For the year ended 31 March 2021, BT Group’s reported revenue was £21,331m with reported profit before taxation of £1,804m.
British Telecommunications plc is a wholly-owned subsidiary of BT Group plc and encompasses virtually all businesses and assets of the BT Group. BT Group plc is listed on the London Stock Exchange.
For more information, visit www.bt.com/about